10/6/2009

A study published in Gut showed long-term use of a proton pump inhibitor didn't increase the risk of esophageal cancer in patients with Barrett's esophagus. Researchers said data included serologic and tissue assessments in 90 Barrett's patients taking the PPI esomeprazole over a two-year period.

Related Summaries